Search results
Results from the WOW.Com Content Network
Subsequently she trained at the University of California, San Francisco and Dana–Farber Cancer Institute. In 2007, she received a masters in public health from Harvard University . [ 1 ] [ 2 ] As of 2021, Ng is a physician at the Dana–Farber Cancer Institute and a professor at Harvard Medical School . [ 3 ]
Mary-Ellen Taplin (born 1960), is a research oncologist at Dana Farber Cancer Institute and Brigham and Women's Hospital in Harvard's Longwood Medical and Academic Area. Taplin is Institute Physician and Director of Clinical Research for the Lank Center for Genitourinary Oncology at Dana Farber Cancer Institute and at the Brigham and Women's ...
Wellesley Hospital (1942–2001); Central Hospital 1957 as a private care centre and later became Sherbourne Health Centre in 2003. [1]The Doctor's Hospital (1953–1997) – merged with Toronto Western Hospital in 1996, merged again with Toronto General Hospital and closed in 1997; site at 340 College Street now home to Kensington Health, a long-term care facility and hospice for seniors. [2]
Irene Ghobrial is an American-Egyptian physician who is a professor at the Dana–Farber Cancer Institute [2] and Harvard Medical School, [1] [3] where her research investigates early detection, mechanisms of disease progression and early interception of multiple myeloma.
On April 30, 2021, the CPSO released a statement on “Public Health Misinformation” accusing Ontario doctors of “using social media to spread blatant misinformation and undermine public health measures.” [10] In response, a group of Canadian physicians released a declaration titled the “Declaration of Canadian Physicians for Science ...
The Princess Margaret Cancer Centre (previously, Princess Margaret Hospital) is a scientific research centre and a teaching hospital in Toronto, Ontario, Canada, affiliated with the University of Toronto Faculty of Medicine as part of the University Health Network.
Griffin completed his residency at Johns Hopkins Hospital, a hematology fellowship at Massachusetts General Hospital, and a medical oncology fellowship at Dana–Farber Cancer Institute. [ 3 ] He is on the scientific advisory boards of Phio Pharmaceuticals , the Georgetown Lombardi Comprehensive Cancer Center , and the Johns Hopkins Cancer Center.
In 2000, Wu joined the Dana-Farber faculty and began her independent research program in 2005. [1]In 2011, Wu was the recipient of a Stand Up To Cancer Innovative Research Grant for her project "Coupled Genetic and Functional Dissection of Chronic Lymphocytic Leukemia."